BIONTECH
LIVE

Serial Number

87523267

Owner

BioNTech SE

Attorney

Brian T. Sniffen

Filing Date

Jul 11, 2017

Add to watchlist:

No watchlists yet
View on USPTO

BIONTECH Trademark

Serial Number: 87523267 • Registration: 5712036

BIONTECH is a trademark filed by BioNTech SE on July 11, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods), Class 31 (Natural Agricultural Products). The application is currently registered and active.

Owner Contact Info

BioNTech SE (46 trademarks)

An der Goldgrube 12

Entity Type: 94

BioNTech AG (6 trademarks)

An der Goldgrube 12
Mainz 55131 , DE

Entity Type: 99

Trademark Details

Filing Date

July 11, 2017

Registration Date

April 2, 2019

Published for Opposition

January 15, 2019

Goods & Services

Pharmaceutical products for the prevention and treatment of cancer, infectious diseases, and immunological diseases, except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Vaccines; [ Adjuvants for medical purposes except vitamin preparations, mineral food supplements, probiotics, omega 3 preparations, dietetic substances and food supplements for medical and non-medical purposes; Chemical reagents used for medical or veterinary purposes; Biochemical reagents used for medical or veterinary purposes for the treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases; Macromolecules, namely, nucleic acid sequences and proteins, used for medical and veterinary purposes; ] cell based immune therapeutics for treatment of cancer, treatment of immunological diseases, and treatment of infectious diseases

[ Pharmaceutical information leaflets; Printed pamphlets, brochures, manuals, books, booklets, leaflets, flyers, informational sheets and newsletters for providing medical, pharmaceutical and scientific research information ]

Active chemical ingredients for use in manufacture of anti-cancer drugs and vaccines [ ; Adjuvants for use in manufacture of vaccines; Protein arrays and nucleotide arrays for scientific and medical laboratory use; Nucleic acids, proteins and peptides for laboratory use; Diagnostic preparations for scientific or research use other than for medical purposes; Diagnostic preparations for clinical or medical laboratory use ]

Medical services, namely, providing therapies for treating cancer, infectious diseases and immunological diseases; [ Veterinary services, namely, providing therapies for treating cancer, infectious diseases, and immunological diseases; Medical and pharmaceutical consultation; ] Medical diagnostic testing, monitoring and reporting services [ ; Genetic testing for medical purposes ]

[ Transgenic live animals and live plants for research and for the production of pharmaceutical, veterinary and biochemical goods ]

Medical and scientific research in the field of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases [ ; Providing medical and scientific research information, consultancy, and advisory services, all in the fields of treatment of immunological diseases, cancer treatment, and treatment of infectious diseases; Compiling data for medical and scientific research, clinical trials, and drug admission ]

Filing History

POST REGISTRATION ACTION MAILED - SEC. 8 & 15
Sep 15, 2025 PR23
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 12, 2025 APRE
TEAS SECTION 8 & 15 RECEIVED
May 1, 2025 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 24, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Feb 24, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 24, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 24, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 24, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 24, 2025 COAR
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Apr 2, 2024 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 29, 2020 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 16, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 16, 2019 REAP
REGISTERED-PRINCIPAL REGISTER
Apr 2, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 15, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jan 15, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 26, 2018 NONP
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 27, 2018 PBCR
ELECTRONIC RECORD REVIEW COMPLETE
Nov 14, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Nov 9, 2018 ERRR
CASE RETURNED TO EXAMINATION
Oct 29, 2018 OTHE
NOTICE OF ALLOWANCE CANCELLED
Oct 29, 2018 IUCN
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Oct 22, 2018 PCBG
ASSIGNED TO PETITION STAFF
Oct 15, 2018 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Sep 27, 2018 TPAD
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 24, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 29, 2018 NPUB
PUBLISHED FOR OPPOSITION
May 29, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 9, 2018 NONP
ELECTRONIC RECORD REVIEW COMPLETE
Apr 20, 2018 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 13, 2018 ERRR
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 8, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
Mar 19, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 19, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 19, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 19, 2018 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2017 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2017 GNRT
NON-FINAL ACTION WRITTEN
Oct 13, 2017 CNRT
ASSIGNED TO EXAMINER
Oct 8, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 17, 2017 NWOS
NEW APPLICATION ENTERED
Jul 14, 2017 NWAP